HCMSG - Hepatitis C Mentor & Support Group, Inc.
Search
  • About Us
    • Our Mission
    • Board of Directors
    • Medical Advisors
  • Resources
    • Corona Virus
    • Hep C Facts & Stats
    • Medications and Treatments >
      • Patient Assistance Programs
    • Reading
    • Links
  • Programs/Training
    • The Circle Model >
      • THE CIRCLE Registration
      • Group and Facilitator Guide
    • Hepatitis C Online Training
    • The Hepatitis C Education and Support Group Assistance Program
    • Healthcare Provider Training
  • Newsletter
  • Blog
  • Support Us
    • Holiday 2020
  • Contact Us

EASL updates liver cancer guidelines at International Liver Congress

4/28/2018

0 Comments

 
Liz Highleyman Published:13 April 2018
INFOHEP

​

​
The European Association for the Study of the Liver (EASL) presented updated clinical practice guidelines for the management of hepatocellular carcinoma (HCC) during a special session at the 2018 International Liver Congress yesterday in Paris. The full guidelines are now available online.
An expert panel made up of hepatologists, oncologists and other specialists developed the recommendations based on an extensive review of relevant studies – the guidelines include more than 600 references – focusing on advances since the guidelines were last updated in 2012. Of note, the number of systemic medications for HCC has risen from just one to half a dozen.
"The rising incidence of HCC in most European countries suggests an insufficient awareness of liver disease in general, calling for public health policies aiming to prevent, detect and treat liver disease—not only for HCC prevention," the panel wrote. "It is particularly frustrating to see most patients with HCC diagnosed at a stage no longer amenable to curative treatment, demonstrating again a neglect of liver disease and appropriate cancer surveillance."
Glossaryhepatocellular carcinoma (HCC)
MORE FROM THE GLOSSARYLiver cancer is the fifth most common cancer and the second leading cause of cancer-related death, with about 854,000 new cases and 810,000 deaths per year, according to the guidelines. About 85% of all cases occur in East Asia and sub-Saharan Africa. HCC accounts for around 90% of primary liver cancers, meaning they originate in the liver. (Cancers that arise elsewhere in the body and spread to the liver are not properly considered liver cancer.)
Over years or decades, chronic hepatitis B or C virus infection, heavy alcohol consumption, fat accumulation in the liver and other causes of liver injury can lead to development of liver cirrhosis and HCC. A majority of liver cancer cases in Asia and Africa are attributable to hepatitis B, while chronic hepatitis C appears to be the major risk factor in Western countries, according to the guidelines. Non-alcoholic fatty liver disease (NAFLD) associated with metabolic syndrome, diabetes and obesity seems to be a growing cause.
Liver cancer is often detected late, when it is difficult to treat. Depending on its stage, HCC may be treated with surgery to remove part of the liver (known as resection), liver transplantation, local therapies to destroy tumours, or systemic drugs – or a combination of these. But many people experience continued disease progression or recurrence and survival is typically measured in months.
The panel made recommendations in several areas:
  • Epidemiology, risk factors and prevention
  • Surveillance
  • Diagnosis and recall policy
  • Staging systems and treatment allocation
  • Response assessment
  • Liver resection
  • Liver transplantation
  • Local ablation and external radiation
  • Transarterial therapies
  • Systemic therapies
  • Palliative and best supportive care. TO CONTINUE READING:​http://www.infohep.org/page/3256817/?utm_source=NAM-Email-Promotion&utm_medium=conference-bulletin&utm_campaign=English
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Archives

    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013
    December 2012
    November 2012
    October 2012
    September 2012
    August 2012
    July 2012
    June 2012
    May 2012
    April 2012
    March 2012
    February 2012
    January 2012
    December 2011
    November 2011
    October 2011
    September 2011
    August 2011
    July 2011
    June 2011
    May 2011

    Categories

    All

    RSS Feed

Privacy Policy